Functional relevance of microbiome signatures: The correlation era requires tools for consolidation

Journal of Allergy and Clinical Immunology

Volumn 139, Issue 4, 2017, Pages 1092-1098

  Buttó, Ludovica F ^a   Haller, Dirk ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

allergy; colorectal cancer; diabetes; fecal microbiota transplantation; gnotobiology; inflammatory bowel diseases; metagenomics; Microbiome; synthetic bacterial consortia

Indexed keywords

ARTICLE; BACTERIUM; GNOTOBIOTICS; HUMAN; METAGENOMICS; MICROBIAL COMMUNITY; MICROBIAL CONSORTIUM; MICROBIOME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RESEARCH; STANDARDIZATION; ANIMAL; BIOLOGICAL MODEL; GENETICS; INTESTINE FLORA; METAGENOME; PROCEDURES; STANDARDS; TRENDS;

ANIMALS; GASTROINTESTINAL MICROBIOME; HUMANS; METAGENOME; METAGENOMICS; MODELS, BIOLOGICAL;

EID: 85017291377     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2017.02.010     Document Type: Article

References (108)

1. 1 Sender, R., Fuchs, S., Milo, R., Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 164 (2016), 337–340.
2. 2 Donaldson, G.P., Lee, S.M., Mazmanian, S.K., Gut biogeography of the bacterial microbiota. Nat Rev Microbiol 14 (2016), 20–32.
3. 3 Turpin, W., Espin-Garcia, O., Xu, W., Silverberg, M.S., Kevans, D., Smith, M.I., et al. Association of host genome with intestinal microbial composition in a large healthy cohort. Nat Genet 48 (2016), 1413–1417.
4. 4 Zeevi, D., Korem, T., Zmora, N., Israeli, D., Rothschild, D., Weinberger, A., et al. Personalized nutrition by prediction of glycemic responses. Cell 163 (2015), 1079–1094.
5. 5 Bokulich, N.A., Chung, J., Battaglia, T., Henderson, N., Jay, M., Li, H., et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med, 8, 2016, 343ra82.
6. 6 Falony, G., Joossens, M., Vieira-Silva, S., Wang, J., Darzi, Y., Faust, K., et al. Population-level analysis of gut microbiome variation. Science 352 (2016), 560–564.
7. 7 Yatsunenko, T., Rey, F.E., Manary, M.J., Trehan, I., Dominguez-Bello, M.G., Contreras, M., et al. Human gut microbiome viewed across age and geography. Nature 486 (2012), 222–227.
8. 8 David, L.A., Maurice, C.F., Carmody, R.N., Gootenberg, D.B., Button, J.E., Wolfe, B.E., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature 505 (2014), 559–563.
9. 9 Lepage, P., Hasler, R., Spehlmann, M.E., Rehman, A., Zvirbliene, A., Begun, A., et al. Twin study indicates loss of interaction between microbiota and mucosa of patients with ulcerative colitis. Gastroenterology 141 (2011), 227–236.
10. 10 Jeffery, I.B., O'Toole, P.W., Ohman, L., Claesson, M.J., Deane, J., Quigley, E.M., et al. An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota. Gut 61 (2012), 997–1006.
11. 11 Fujimura, K.E., Sitarik, A.R., Havstad, S., Lin, D.L., Levan, S., Fadrosh, D., et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med 22 (2016), 1187–1191.
12. 12 Van de Wiele, T., Van Praet, J.T., Marzorati, M., Drennan, M.B., Elewaut, D., How the microbiota shapes rheumatic diseases. Nat Rev Rheumatol 12 (2016), 398–411.
13. 13 Kostic, A.D., Gevers, D., Siljander, H., Vatanen, T., Hyotylainen, T., Hamalainen, A.M., et al. The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes. Cell Host Microbe 17 (2015), 260–273.
14. 14 Le Chatelier, E., Nielsen, T., Qin, J., Prifti, E., Hildebrand, F., Falony, G., et al. Richness of human gut microbiome correlates with metabolic markers. Nature 500 (2013), 541–546.
15. 15 Pedersen, H.K., Gudmundsdottir, V., Nielsen, H.B., Hyotylainen, T., Nielsen, T., Jensen, B.A., et al. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature 535 (2016), 376–381.
16. 16 Serino, M., Blasco-Baque, V., Nicolas, S., Burcelin, R., Far from the eyes, close to the heart: dysbiosis of gut microbiota and cardiovascular consequences. Curr Cardiol Rep, 16, 2014, 540.
17. 17 Hsiao, E.Y., McBride, S.W., Hsien, S., Sharon, G., Hyde, E.R., McCue, T., et al. Microbiota modulate behavioral and physiological abnormalities associated with neurodevelopmental disorders. Cell 155 (2013), 1451–1463.
18. 18 Koeth, R.A., Wang, Z., Levison, B.S., Buffa, J.A., Org, E., Sheehy, B.T., et al. Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis. Nat Med 19 (2013), 576–585.
19. 19 Chen, Y., Ji, F., Guo, J., Shi, D., Fang, D., Li, L., Dysbiosis of small intestinal microbiota in liver cirrhosis and its association with etiology. Sci Rep, 6, 2016, 34055.
20. 20 Hanage, W.P., Microbiology: microbiome science needs a healthy dose of scepticism. Nature 512 (2014), 247–248.
21. 21 Bashan, A., Gibson, T.E., Friedman, J., Carey, V.J., Weiss, S.T., Hohmann, E.L., et al. Universality of human microbial dynamics. Nature 534 (2016), 259–262.
22. 22 Integrative, H.M.P., (iHMP) Research Network Consortium. The Integrative Human Microbiome Project: dynamic analysis of microbiome-host omics profiles during periods of human health and disease. Cell Host Microbe 16 (2014), 276–289.
23. 23 Gevers, D., Kugathasan, S., Denson, L.A., Vazquez-Baeza, Y., Van Treuren, W., Ren, B., et al. The treatment-naive microbiome in new-onset Crohn's disease. Cell Host Microbe 15 (2014), 382–392.
24. 24 Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490 (2012), 55–60.
25. 25 Karlsson, F., Tremaroli, V., Nielsen, J., Backhed, F., Assessing the human gut microbiota in metabolic diseases. Diabetes 62 (2013), 3341–3349.
26. 26 Forslund, K., Hildebrand, F., Nielsen, T., Falony, G., Le Chatelier, E., Sunagawa, S., et al. Disentangling type 2 diabetes and metformin treatment signatures in the human gut microbiota. Nature 528 (2015), 262–266.
27. 27 Vrieze, A., Van Nood, E., Holleman, F., Salojarvi, J., Kootte, R.S., Bartelsman, J.F., et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 143 (2012), 913–916.e7.
28. 28 Cammarota, G., Ianiro, G., Tilg, H., Rajilic-Stojanovic, M., Kump, P., Satokari, R., et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut, 2017 [Epub ahead of print].
29. 29 Li, S.S., Zhu, A., Benes, V., Costea, P.I., Hercog, R., Hildebrand, F., et al. Durable coexistence of donor and recipient strains after fecal microbiota transplantation. Science 352 (2016), 586–589.
30. 30 Ott, S.J., Waetzig, G.H., Rehman, A., Moltzau-Anderson, J., Bharti, R., Grasis, J.A., et al. Efficacy of sterile fecal filtrate transfer for treating patients with Clostridium difficile infection. Gastroenterology, 2016 [Epub ahead of print].
31. 31 de Souza, H.S., Fiocchi, C., Immunopathogenesis of IBD: current state of the art. Nat Rev Gastroenterol Hepatol 13 (2016), 13–27.
32. 32 Jostins, L., Ripke, S., Weersma, R.K., Duerr, R.H., McGovern, D.P., Hui, K.Y., et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491 (2012), 119–124.
33. 33 Busquets, D., Mas-de-Xaxars, T., Lopez-Siles, M., Martinez-Medina, M., Bahi, A., Sabat, M., et al. Anti-tumour necrosis factor treatment with adalimumab induces changes in the microbiota of Crohn's disease. J Crohns Colitis 9 (2015), 899–906.
34. 34 Lee, T., Clavel, T., Smirnov, K., Schmidt, A., Lagkouvardos, I., Walker, A., et al. Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut, 2016 [Epub ahead of print].
35. 35 Haberman, Y., Tickle, T.L., Dexheimer, P.J., Kim, M.O., Tang, D., Karns, R., et al. Pediatric Crohn disease patients exhibit specific ileal transcriptome and microbiome signature. J Clin Invest 124 (2014), 3617–3633.
36. 36 Moayyedi, P., Surette, M.G., Kim, P.T., Libertucci, J., Wolfe, M., Onischi, C., et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 149 (2015), 102–109.e6.
37. 37 Rossen, N.G., Fuentes, S., van der Spek, M.J., Tijssen, J.G., Hartman, J.H., Duflou, A., et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 149 (2015), 110–118.e4.
38. 38 Paramsothy, S., Kamm, M.A., Kaakoush, N.O., Walsh, A.J., van den Bogaerde, J., Samuel, D., et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet, 2017 [Epub ahead of print].
39. 39 Schwerd, T., Frivolt, K., Clavel, T., Lagkouvardos, I., Katona, G., Mayr, D., et al. Exclusive enteral nutrition in active pediatric Crohn disease: effects on intestinal microbiota and immune regulation. J Allergy Clin Immunol 138 (2016), 592–596.
40. 40 Lewis, J.D., Chen, E.Z., Baldassano, R.N., Otley, A.R., Griffiths, A.M., Lee, D., et al. Inflammation, antibiotics, and diet as environmental stressors of the gut microbiome in pediatric Crohn's disease. Cell Host Microbe 18 (2015), 489–500.
41. 41 Simpson, A., Tan, V.Y., Winn, J., Svensen, M., Bishop, C.M., Heckerman, D.E., et al. Beyond atopy: multiple patterns of sensitization in relation to asthma in a birth cohort study. Am J Respir Crit Care Med 181 (2010), 1200–1206.
42. 42 Arrieta, M.C., Stiemsma, L.T., Dimitriu, P.A., Thorson, L., Russell, S., Yurist-Doutsch, S., et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med, 7, 2015, 307ra152.
43. 43 Rehman, A., Rausch, P., Wang, J., Skieceviciene, J., Kiudelis, G., Bhagalia, K., et al. Geographical patterns of the standing and active human gut microbiome in health and IBD. Gut 65 (2016), 238–248.
44. 44 Joossens, M., Huys, G., Cnockaert, M., De Preter, V., Verbeke, K., Rutgeerts, P., et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 60 (2011), 631–637.
45. 45 Jalanka-Tuovinen, J., Salojarvi, J., Salonen, A., Immonen, O., Garsed, K., Kelly, F.M., et al. Faecal microbiota composition and host-microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome. Gut 63 (2014), 1737–1745.
46. 46 Fujimura, K.E., Lynch, S.V., Microbiota in allergy and asthma and the emerging relationship with the gut microbiome. Cell Host Microbe 17 (2015), 592–602.
47. 47 Azad, M.B., Konya, T., Guttman, D.S., Field, C.J., Sears, M.R., HayGlass, K.T., et al. Infant gut microbiota and food sensitization: associations in the first year of life. Clin Exp Allergy 45 (2015), 632–643.
48. 48 Zhang, X., Zhang, D., Jia, H., Feng, Q., Wang, D., Liang, D., et al. The oral and gut microbiomes are perturbed in rheumatoid arthritis and partly normalized after treatment. Nat Med 21 (2015), 895–905.
49. 49 Chen, J., Chia, N., Kalari, K.R., Yao, J.Z., Novotna, M., Soldan, M.M., et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep, 6, 2016, 28484.
50. 50 Jangi, S., Gandhi, R., Cox, L.M., Li, N., von Glehn, F., Yan, R., et al. Alterations of the human gut microbiome in multiple sclerosis. Nat Commun, 7, 2016, 12015.
51. 51 Karlsson, F.H., Tremaroli, V., Nookaew, I., Bergstrom, G., Behre, C.J., Fagerberg, B., et al. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature 498 (2013), 99–103.
52. 52 De Angelis, M., Piccolo, M., Vannini, L., Siragusa, S., De Giacomo, A., Serrazzanetti, D.I., et al. Fecal microbiota and metabolome of children with autism and pervasive developmental disorder not otherwise specified. PLoS One, 8, 2013, e76993.
53. 53 Wang, L., Christophersen, C.T., Sorich, M.J., Gerber, J.P., Angley, M.T., Conlon, M.A., Increased abundance of Sutterella spp. and Ruminococcus torques in feces of children with autism spectrum disorder. Mol Autism, 4, 2013, 42.
54. 54 Kang, D.W., Park, J.G., Ilhan, Z.E., Wallstrom, G., Labaer, J., Adams, J.B., et al. Reduced incidence of Prevotella and other fermenters in intestinal microflora of autistic children. PLoS One, 8, 2013, e68322.
55. 55 Sears, C.L., Garrett, W.S., Microbes, microbiota, and colon cancer. Cell Host Microbe 15 (2014), 317–328.
56. 56 Feng, Q., Liang, S., Jia, H., Stadlmayr, A., Tang, L., Lan, Z., et al. Gut microbiome development along the colorectal adenoma-carcinoma sequence. Nat Commun, 6, 2015, 6528.
57. 57 O'Keefe, S.J., Li, J.V., Lahti, L., Ou, J., Carbonero, F., Mohammed, K., et al. Fat, fibre and cancer risk in African Americans and rural Africans. Nat Commun, 6, 2015, 6342.
58. 58 Zeller, G., Tap, J., Voigt, A.Y., Sunagawa, S., Kultima, J.R., Costea, P.I., et al. Potential of fecal microbiota for early-stage detection of colorectal cancer. Mol Syst Biol, 10, 2014, 766.
59. 59 Flemer, B., Lynch, D.B., Brown, J.M., Jeffery, I.B., Ryan, F.J., Claesson, M.J., et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut, 2016 [Epub ahead of print].
60. 60 Qin, N., Yang, F., Li, A., Prifti, E., Chen, Y., Shao, L., et al. Alterations of the human gut microbiome in liver cirrhosis. Nature 513 (2014), 59–64.
61. 61 Lozupone, C.A., Stombaugh, J.I., Gordon, J.I., Jansson, J.K., Knight, R., Diversity, stability and resilience of the human gut microbiota. Nature 489 (2012), 220–230.
62. 62 Tyler, A.D., Smith, M.I., Silverberg, M.S., Analyzing the human microbiome: a “how to” guide for physicians. Am J Gastroenterol 109 (2014), 983–993.
63. 63 Dave, M., Higgins, P.D., Middha, S., Rioux, K.P., The human gut microbiome: current knowledge, challenges, and future directions. Transl Res 160 (2012), 246–257.
64. 64 Escalona, M., Rocha, S., Posada, D., A comparison of tools for the simulation of genomic next-generation sequencing data. Nat Rev Genet 17 (2016), 459–469.
65. 65 Hiergeist, A., Reischl, U., Priority Program 1656 Intestinal Microbiota Consortium/ quality assessment participants, Gessner A. Multicenter quality assessment of 16S ribosomal DNA-sequencing for microbiome analyses reveals high inter-center variability. Int J Med Microbiol 306 (2016), 334–342.
66. 66 Nielsen, H.B., Almeida, M., Juncker, A.S., Rasmussen, S., Li, J., Sunagawa, S., et al. Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat Biotechnol 32 (2014), 822–828.
67. 67 Sunagawa, S., Mende, D.R., Zeller, G., Izquierdo-Carrasco, F., Berger, S.A., Kultima, J.R., et al. Metagenomic species profiling using universal phylogenetic marker genes. Nat Methods 10 (2013), 1196–1199.
68. 68 Donia, M.S., Fischbach, M.A., Human microbiota. Small molecules from the human microbiota. Science, 349, 2015, 1254766.
69. 69 Guo, C.J., Chang, F.Y., Wyche, T.P., Backus, K.M., Acker, T.M., Funabashi, M., et al. Discovery of reactive microbiota-derived metabolites that inhibit host proteases. Cell 168 (2017), 517–526.e18.
70. 70 Devlin, A.S., Fischbach, M.A., A biosynthetic pathway for a prominent class of microbiota-derived bile acids. Nat Chem Biol 11 (2015), 685–690.
71. 71 Browne, H.P., Forster, S.C., Anonye, B.O., Kumar, N., Neville, B.A., Stares, M.D., et al. Culturing of ‘unculturable’ human microbiota reveals novel taxa and extensive sporulation. Nature 533 (2016), 543–546.
72. 72 Lagkouvardos, I., Pukall, R., Abt, B., Foesel, B.U., Meier-Kolthoff, J.P., Kumar, N., et al. The Mouse Intestinal Bacterial Collection (miBC) provides host-specific insight into cultured diversity and functional potential of the gut microbiota. Nat Microbiol, 1, 2016, 16131.
73. 73 Qin, J., Li, R., Raes, J., Arumugam, M., Burgdorf, K.S., Manichanh, C., et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464 (2010), 59–65.
74. 74 Xiao, L., Feng, Q., Liang, S., Sonne, S.B., Xia, Z., Qiu, X., et al. A catalog of the mouse gut metagenome. Nat Biotechnol 33 (2015), 1103–1108.
75. 75 Xiao, L., Estelle, J., Kiilerich, P., Ramayo-Caldas, Y., Xia, Z., Feng, Q., et al. A reference gene catalogue of the pig gut microbiome. Nat Microbiol, 2016 [Epub ahead of print].
76. 76 Brugiroux, S., Beutler, M., Pfann, C., Garzetti, D., Ruscheweyh, H.J., Ring, D., et al. Genome-guided design of a defined mouse microbiota that confers colonization resistance against Salmonella enterica serovar Typhimurium. Nat Microbiol, 2, 2016, 16215.
77. 77 Hormannsperger, G., Schaubeck, M., Haller, D., Intestinal microbiota in animal models of inflammatory diseases. ILAR J 56 (2015), 179–191.
78. 78 Buttó, L.F., Schaubeck, M., Haller, D., Mechanisms of microbe-host-interaction in Crohn's disease: dysbiosis vs. pathobiont selection. Front Immunol, 6, 2015, 555.
79. 79 Mazmanian, S.K., Round, J.L., Kasper, D.L., A microbial symbiosis factor prevents intestinal inflammatory disease. Nature 453 (2008), 620–625.
80. 80 Steck, N., Hoffmann, M., Sava, I.G., Kim, S.C., Hahne, H., Tonkonogy, S.L., et al. Enterococcus faecalis metalloprotease compromises epithelial barrier and contributes to intestinal inflammation. Gastroenterology 141 (2011), 959–971.
81. 81 von Schillde, M.A., Hormannsperger, G., Weiher, M., Alpert, C.A., Hahne, H., Bauerl, C., et al. Lactocepin secreted by Lactobacillus exerts anti-inflammatory effects by selectively degrading proinflammatory chemokines. Cell Host Microbe 11 (2012), 387–396.
82. 82 Gronbach, K., Flade, I., Holst, O., Lindner, B., Ruscheweyh, H.J., Wittmann, A., et al. Endotoxicity of lipopolysaccharide as a determinant of T-cell-mediated colitis induction in mice. Gastroenterology 146 (2014), 765–775.
83. 83 Eun, C.S., Mishima, Y., Wohlgemuth, S., Liu, B., Bower, M., Carroll, I.M., et al. Induction of bacterial antigen-specific colitis by a simplified human microbiota consortium in gnotobiotic interleukin-10-/- mice. Infect Immun 82 (2014), 2239–2246.
84. 84 Rausch, P., Basic, M., Batra, A., Bischoff, S.C., Blaut, M., Clavel, T., et al. Analysis of factors contributing to variation in the C57BL/6J fecal microbiota across German animal facilities. Int J Med Microbiol 306 (2016), 343–355.
85. 85 Schaubeck, M., Clavel, T., Calasan, J., Lagkouvardos, I., Haange, S.B., Jehmlich, N., et al. Dysbiotic gut microbiota causes transmissible Crohn's disease-like ileitis independent of failure in antimicrobial defence. Gut 65 (2016), 225–237.
86. 86 Garrett, W.S., Gallini, C.A., Yatsunenko, T., Michaud, M., DuBois, A., Delaney, M.L., et al. Enterobacteriaceae act in concert with the gut microbiota to induce spontaneous and maternally transmitted colitis. Cell Host Microbe 8 (2010), 292–300.
87. 87 Couturier-Maillard, A., Secher, T., Rehman, A., Normand, S., De Arcangelis, A., Haesler, R., et al. NOD2-mediated dysbiosis predisposes mice to transmissible colitis and colorectal cancer. J Clin Invest 123 (2013), 700–711.
88. 88 Wen, L., Ley, R.E., Volchkov, P.Y., Stranges, P.B., Avanesyan, L., Stonebraker, A.C., et al. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455 (2008), 1109–1113.
89. 89 Berer, K., Mues, M., Koutrolos, M., Rasbi, Z.A., Boziki, M., Johner, C., et al. Commensal microbiota and myelin autoantigen cooperate to trigger autoimmune demyelination. Nature 479 (2011), 538–541.
90. 90 Vijay-Kumar, M., Aitken, J.D., Carvalho, F.A., Cullender, T.C., Mwangi, S., Srinivasan, S., et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 328 (2010), 228–231.
91. 91 Turnbaugh, P.J., Ley, R.E., Mahowald, M.A., Magrini, V., Mardis, E.R., Gordon, J.I., An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 444 (2006), 1027–1031.
92. 92 Rabot, S., Membrez, M., Blancher, F., Berger, B., Moine, D., Krause, L., et al. High fat diet drives obesity regardless the composition of gut microbiota in mice. Sci Rep, 6, 2016, 32484.
93. 93 Backhed, F., Manchester, J.K., Semenkovich, C.F., Gordon, J.I., Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc Natl Acad Sci U S A 104 (2007), 979–984.
94. 94 Kubeck, R., Bonet-Ripoll, C., Hoffmann, C., Walker, A., Muller, V.M., Schuppel, V.L., et al. Dietary fat and gut microbiota interactions determine diet-induced obesity in mice. Mol Metab 5 (2016), 1162–1174.
95. 95 Turnbaugh, P.J., Hamady, M., Yatsunenko, T., Cantarel, B.L., Duncan, A., Ley, R.E., et al. A core gut microbiome in obese and lean twins. Nature 457 (2009), 480–484.
96. 96 Nagao-Kitamoto, H., Shreiner, A.B., Gillilland, M.G. 3rd, Kitamoto, S., Ishii, C., Hirayama, A., et al. Functional characterization of inflammatory bowel disease-associated gut dysbiosis in gnotobiotic mice. Cell Mol Gastroenterol Hepatol 2 (2016), 468–481.
97. 97 Crouzet, L., Gaultier, E., Del'Homme, C., Cartier, C., Delmas, E., Dapoigny, M., et al. The hypersensitivity to colonic distension of IBS patients can be transferred to rats through their fecal microbiota. Neurogastroenterol Motil 25 (2013), e272–e282.
98. 98 Arrieta, M.C., Sadarangani, M., Brown, E.M., Russell, S.L., Nimmo, M., Dean, J., et al. A humanized microbiota mouse model of ovalbumin-induced lung inflammation. Gut Microbes 7 (2016), 342–352.
99. 99 Ridaura, V.K., Faith, J.J., Rey, F.E., Cheng, J., Duncan, A.E., Kau, A.L., et al. Gut microbiota from twins discordant for obesity modulate metabolism in mice. Science, 341, 2013, 1241214.
100. 100 Vetizou, M., Pitt, J.M., Daillere, R., Lepage, P., Waldschmitt, N., Flament, C., et al. Anticancer immunotherapy by CTLA-4 blockade relies on the gut microbiota. Science 350 (2015), 1079–1084.
101. 101 Sivan, A., Corrales, L., Hubert, N., Williams, J.B., Aquino-Michaels, K., Earley, Z.M., et al. Commensal Bifidobacterium promotes antitumor immunity and facilitates anti-PD-L1 efficacy. Science 350 (2015), 1084–1089.
102. 102 Arrieta, M.C., Walter, J., Finlay, B.B., Human microbiota-associated mice: a model with challenges. Cell Host Microbe 19 (2016), 575–578.
103. 103 Chung, H., Pamp, S.J., Hill, J.A., Surana, N.K., Edelman, S.M., Troy, E.B., et al. Gut immune maturation depends on colonization with a host-specific microbiota. Cell 149 (2012), 1578–1593.
104. 104 Rawls, J.F., Mahowald, M.A., Ley, R.E., Gordon, J.I., Reciprocal gut microbiota transplants from zebrafish and mice to germ-free recipients reveal host habitat selection. Cell 127 (2006), 423–433.
105. 105 Li, H., Limenitakis, J.P., Fuhrer, T., Geuking, M.B., Lawson, M.A., Wyss, M., et al. The outer mucus layer hosts a distinct intestinal microbial niche. Nat Commun, 6, 2015, 8292.
106. 106 Johansson, M.E., Hansson, G.C., Immunological aspects of intestinal mucus and mucins. Nat Rev Immunol 16 (2016), 639–649.
107. 107 Du, Z., Hudcovic, T., Mrazek, J., Kozakova, H., Srutkova, D., Schwarzer, M., et al. Development of gut inflammation in mice colonized with mucosa-associated bacteria from patients with ulcerative colitis. Gut Pathog, 7, 2015, 32.
108. 108 Marcobal, A., Kashyap, P.C., Nelson, T.A., Aronov, P.A., Donia, M.S., Spormann, A., et al. A metabolomic view of how the human gut microbiota impacts the host metabolome using humanized and gnotobiotic mice. ISME J 7 (2013), 1933–1943.